Type 1 Diabetes Treatment Trial
Drug Updates

vTv Therapeutics Announces FDA Submission for First Phase 3 Study of Cadisegliatin in Patients with Type 1 Diabetes

vTv Therapeutics Inc. (Nasdaq: VTVT), a clinical stage biopharmaceutical company focused on the development of cadisegliatin (TTP399) as an adjunctive therapy to insulin for the treatment of type 1 diabetes (“T1D”), today announced the submission of the study protocol to the FDA for the Company’s first Phase 3 trial evaluating the safety and efficacy of its lead […]

Drug Updates

AbbVie Announces Positive Topline Results from Phase 2 LUMINOSITY Trial Evaluating Telisotuzumab-Vedotin (Teliso-V) for Patients with Previously Treated Non-Small Cell Lung Cancer (NSCLC)

AbbVie (NYSE: ABBV) announced today topline results from the single-arm Phase 2 LUMINOSITY trial evaluating telisotuzumab-vedotin (Teliso-V) in patients with c-Met protein overexpression, epidermal growth factor receptor (EGFR) wild type, advanced/metastatic nonsquamous non-small cell lung cancer (NSCLC). The results demonstrated a compelling overall response rate per independent central review (ICR) of 35 percent and 23 percent […]

Pandemic Pulse

PHD Family Welfare Foundation leads the fight against a possible 3rd wave of Covid-19 with installation of medical oxygen generation plant at Medicheck Hospital at Faridabad, Haryana

NEW DELHI: While preparing to fight for a possible third wave of Covid-19, PHD Family Welfare Foundation (PHDFWF), which is a wing of the national apex chamber PHD Chamber of Commerce and Industry (PHDCCI), has inaugurated an oxygen generation plant at Medicheck Hospital at Faridabad in Haryana on June 30, 2021. Shri Krishan Pal Gurjar, […]